Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,574 | 139,220 | 38,270 | 77,743 | 73,441 |
| Marketable Securities | 120,795 | 39,544 | 39,053 | 9,923 | 19,739 |
| Other current assets | 515 | 1,002 | 596 | 446 | 53 |
| TOTAL | $172,177 | $180,109 | $78,537 | $88,795 | $94,165 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 24 | 48 |
| Other Non-Current Assets | 1,156 | 1,095 | 1,058 | 35 | 69 |
| TOTAL | $1,156 | $1,095 | $1,058 | $59 | $117 |
| Total Assets | $173,332 | $181,205 | $79,595 | $88,853 | $94,281 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,587 | 1,158 | 621 | 2,704 | 1,692 |
| Accrued Expenses | 4,125 | 4,081 | 3,656 | 3,146 | 3,513 |
| Other current liabilities | N/A | 3,062 | 2,419 | 2,912 | 3,271 |
| TOTAL | $5,712 | $8,301 | $6,696 | $8,800 | $8,551 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,712 | $8,301 | $6,696 | $8,800 | $8,551 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 132,033 | 132,033 | 75,175 | 74,517 | 74,342 |
| Common Shares | 132 | 132 | 75 | 75 | 74 |
| Retained earnings | -159,061 | -142,680 | -129,945 | -118,015 | -108,099 |
| Other shareholders' equity | -26 | 22 | -4 | -3 | -1 |
| TOTAL | $167,620 | $172,904 | $72,898 | $80,054 | $85,731 |
| Total Liabilities And Equity | $173,332 | $181,205 | $79,595 | $88,853 | $94,281 |